Effect of sitagliptin monotherapy on serum total ghrelin levels in people with type 2 diabetes.

Trial Profile

Effect of sitagliptin monotherapy on serum total ghrelin levels in people with type 2 diabetes.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Dec 2011

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Dec 2011 New trial record
    • 01 Nov 2011 Results published in the Diabetes Research and Clinical Practice.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top